|1.||Friedman, Mendel: 2 articles (04/2015 - 01/2003)|
|2.||Ranpariya, Vishavas: 2 articles (02/2014 - 02/2011)|
|3.||Parmar, Sachin: 2 articles (02/2014 - 02/2011)|
|4.||Sheth, Navin: 2 articles (02/2014 - 02/2011)|
|5.||Wang, De-Feng: 1 article (12/2015)|
|6.||Zhao, Guo-Dong: 1 article (12/2015)|
|7.||Liu, Zhao-Peng: 1 article (12/2015)|
|8.||Xie, Fei: 1 article (12/2015)|
|9.||Liu, Chao: 1 article (12/2015)|
|10.||Lou, Hong-Xiang: 1 article (12/2015)|
02/01/2011 - "Interestingly, solasodine did not produce any significant reduction in PTZ-induced convulsions. "
02/01/2011 - "sisymbriifolium and identified by GC-MS. The results showed that intraperitoneal (i.p.) injection of solasodine (25 mg/kg) significantly delayed (p < 0.01) latency of hind limb tonic extensor (HLTE) phase in the PCT-induced convulsions. "
|3.||Basal Cell Carcinoma (Rodent Ulcer)
01/01/2008 - "We conclude that the solasodine glycoside cream Zycure is a safe therapy for basal cell carcinoma, with a cure rate of 66% at 8 weeks and 78% at 1 year follow-up."
01/01/2008 - "Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. "
01/01/2008 - "To assess the safety and efficacy of a 0.005% mixture of solasodine glycosides (Zycure) in the treatment of basal cell carcinoma. "
|4.||Body Weight (Weight, Body)
01/01/2003 - "In non-pregnant mice, observed ratios of % liver weights to body weights (%LW/BWs) were significantly greater than those of the control values as follows (all values in % vs matched controls+/-S.D.): solanidine, 25.5+/-13.2; solasodine 16.8+/-12.0; and tomatidine, 6.0+/-7.1. "
01/01/2003 - "For pregnant mice (a) body weight gains were less with the algycones than with controls: solanidine, -36.1+/-14.5; solasodine, -17.9+/-14.3; tomatidine, -11.9+/-18.1; (b) litter weights were less than controls: solanidine, -27.0+/-17.1; solasodine, -15.5+/-16.8; tomatidine, no difference; (c) the %LTW/BW ratio was less than that of the controls and was significant only for solasodine, -8.7+/-13.7; and (d) the average weight of the fetuses was less than the controls: solanidine, -11.2+/-15.2; solasodine, -11.4+/-9.4; tomatidine, no difference. "
02/15/2014 - "Taken together, our study, for the first time, demonstrates neuroprotective potential of solasodine against global ischemia-induced cerebral injury in experimental rats. "
02/15/2014 - "In the present study, we evaluated neuroprotective potential of solasodine, an antioxidant glycoalkaloid of Solanum species, against global model of ischemia in rats. "